Press Releases Ypsomed Group

Burgdorf - Ypsomed AG, Burgdorf, and Adval Tech Holding Ltd, Niederwangen, have signed an agreement on a strategic cooperation in moldmaking. The goal of this agreement is to combine the respective strengths and core competencies of Ypsomed and Adval Tech and exploit them for the economical manufacturing of highquality medtec products.

Press Releases Ypsomed Group

Burgdorf - In business year 2006/07 the Ypsomed Group posted consolidated sales of CHF 277.5 million (-10.7% prior year), returning to profitability as announced in the second half of the year with consolidated net profits of CHF 2.7 million.

Burgdorf - Ypsomed is pleased to announce that it has granted to a major, globally acting pharmaceutical company a non exclusive license to use certain patents, which protect inventions of Ypsomed in the area of auto-injector technology. Ypsomed expects to receive several million Swiss Francs in license fees over the term of the concluded agreement.

Press Releases Ypsomed Group

Burgdorf - After a phase of above average growth in sales and profit the Ypsomed Group is currently in a period of consolidation. In the frist half year 2006/07 (April 1 – September 1 2006) sales fell 8.8% to a total of CHF 129.0 million and a operating loss of CHF 5.3 million.

Press Releases Ypsomed Group

Burgdorf - Ypsomed today has to issue an ad-hoc information due to lower than expected orders for insulin pen systems. Therefore sales and profitability for the business year 2006/07 will be lower than forecasted so far. At the same time Ypsomed announced the change of the CEO.